Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
With a Generous Gift, Couple Creates a Legacy for Loved One
When Jeanne and John Hubbard got involved with The Leukemia & Lymphoma Society in 2015, they didn’t know how closely cancer would touch their lives.
Research
X4 Pharmaceuticals Completes Enrollment in Phase 3 Mavorixafor Trial in Patients with WHIM Syndrome
BOSTON, Oct. 04, 2021 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR) announced today that it has completed enrollment in the ongoing pivotal Phase 3 clinic…
Patient Education Webcasts
Living With Chronic Myeloid Leukemia (CML)
News
New Study Shows Most Blood Cancer Patients Benefit from an Additional COVID-19 Vaccine Dose
More than one in two patients with B-cell blood cancers produced antibodies to a third dose of COVID-19 vaccine despite having no detectable antibodie…
BACK-TO-SCHOOL SAFETY
As the new school year began across the country and shifted back to more in-person learning, LLS heard from families affected by blood cancer. Whether…
Georgia Blood Cancer Conference 2021
Free Educational Conference for Patients, Survivors, Caregivers and Healthcare Professionals*
Research
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals
Planegg/Munich, Germany, July 15, 2021 - MorphoSys announced the successful completion of its previously announced cash tender offer for all outstandi…
Research
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform
Waltham, Mass., August 18, 2021 – Immunitas Therapeutics (“Immunitas”), a single cell genomics-based therapeutics company, today announced the complet…
Media resources
Email
Contact us for inquiries and interview requests.
Press Kit
Explore details for journalists and media outlets.
Brand Center
Access approved logos, guidelines, and other assets.